110 related articles for article (PubMed ID: 10697522)
41. Identification and functional analysis of genes which confer resistance to cisplatin in tumor cells.
Wu ZZ; Lu HP; Chao CC
Biochem Pharmacol; 2010 Jul; 80(2):262-76. PubMed ID: 20361941
[TBL] [Abstract][Full Text] [Related]
42. [Cancer-associated gene abnormalities and chemosensitivity].
Sakamoto M; Umayahara K; Sakamoto H; Kawasaki K; Suehiro Y; Kunugi T; Akiya T; Iwabuchi H; Sakunaga H; Muroya T; Kikuchi Y; Sugishita T; Tenjin Y; Gray JW; Tanaka T
Gan To Kagaku Ryoho; 1998 Oct; 25(12):1819-31. PubMed ID: 9797804
[TBL] [Abstract][Full Text] [Related]
43. Suppression of high-density magnetic field (400 mT at 50 Hz)-induced mutations by wild-type p53 expression in human osteosarcoma cells.
Miyakoshi J; Mori Y; Yamagishi N; Yagi K; Takebe H
Biochem Biophys Res Commun; 1998 Feb; 243(2):579-84. PubMed ID: 9480851
[TBL] [Abstract][Full Text] [Related]
44. [p53 antioncogene abnormal in osteosarcoma].
Guo W; Wang SW; Feng CH
Zhonghua Wai Ke Za Zhi; 1994 Jul; 32(7):412-5. PubMed ID: 7842979
[TBL] [Abstract][Full Text] [Related]
45. Drug resistance and cross-sensitivity in cultured human osteosarcoma cells.
Tomita K; Kontani T; Tsuchiya H; Nomura S
Nihon Seikeigeka Gakkai Zasshi; 1989 Apr; 63(4):274-81. PubMed ID: 2738428
[TBL] [Abstract][Full Text] [Related]
46. Effect of retinoblastoma tumor suppressor gene expression on chemosensitivity of human osteosarcoma cell lines.
Iida K; Nobori T; Matsumine A; Isaka A; Seto M; Shiraishi T; Uchida A
Oncol Rep; 2003; 10(6):1961-5. PubMed ID: 14534726
[TBL] [Abstract][Full Text] [Related]
47. Role of glutathione in cisplatin resistance in osteosarcoma cell lines.
Komiya S; Gebhardt MC; Mangham DC; Inoue A
J Orthop Res; 1998 Jan; 16(1):15-22. PubMed ID: 9565068
[TBL] [Abstract][Full Text] [Related]
48. Identification of drug-regulated genes in osteosarcoma cells.
Fellenberg J; Dechant MJ; Ewerbeck V; Mau H
Int J Cancer; 2003 Jul; 105(5):636-43. PubMed ID: 12740912
[TBL] [Abstract][Full Text] [Related]
49. p53 overexpression increases chemosensitivity in multidrug-resistant osteosarcoma cell lines.
Ye S; Shen J; Choy E; Yang C; Mankin H; Hornicek F; Duan Z
Cancer Chemother Pharmacol; 2016 Feb; 77(2):349-56. PubMed ID: 26698867
[TBL] [Abstract][Full Text] [Related]
50. A novel charged trinuclear platinum complex effective against cisplatin-resistant tumours: hypersensitivity of p53-mutant human tumour xenografts.
Pratesi G; Perego P; Polizzi D; Righetti SC; Supino R; Caserini C; Manzotti C; Giuliani FC; Pezzoni G; Tognella S; Spinelli S; Farrell N; Zunino F
Br J Cancer; 1999 Aug; 80(12):1912-9. PubMed ID: 10471039
[TBL] [Abstract][Full Text] [Related]
51. HMGB1 promotes drug resistance in osteosarcoma.
Huang J; Ni J; Liu K; Yu Y; Xie M; Kang R; Vernon P; Cao L; Tang D
Cancer Res; 2012 Jan; 72(1):230-8. PubMed ID: 22102692
[TBL] [Abstract][Full Text] [Related]
52. Cisplatin.
Dabholkar M; Reed E
Cancer Chemother Biol Response Modif; 1996; 16():88-110. PubMed ID: 8639408
[No Abstract] [Full Text] [Related]
53. Sensitization of rat glioblastoma multiforme to cisplatin in vivo following restoration of wild-type p53 function.
Dorigo O; Turla ST; Lebedeva S; Gjerset RA
J Neurosurg; 1998 Mar; 88(3):535-40. PubMed ID: 9488309
[TBL] [Abstract][Full Text] [Related]
54. [Effects of wild-type p53 gene transfection on the growth and cisplatin sensitivity of cervical cancer cell line HeLa].
Wang X; Peng Z; Wang H
Hua Xi Yi Ke Da Xue Xue Bao; 2002 Jan; 33(1):40-2. PubMed ID: 12599424
[TBL] [Abstract][Full Text] [Related]
55. Cisplatin-induced genes as potential markers for thyroid cancer.
Lapouge G; Millon R; Muller D; Abecassis J; Eber M; Bergerat JP; Klein-Soyer C
Cell Mol Life Sci; 2005 Jan; 62(1):53-64. PubMed ID: 15619007
[TBL] [Abstract][Full Text] [Related]
56. Overexpression of inosine 5'-monophosphate dehydrogenase type II mediates chemoresistance to human osteosarcoma cells.
Fellenberg J; Kunz P; Sähr H; Depeweg D
PLoS One; 2010 Aug; 5(8):e12179. PubMed ID: 20808934
[TBL] [Abstract][Full Text] [Related]
57. Monoallelic deletion of the p53 gene through chromosomal translocation in a small cell osteosarcoma.
Nishio J; Gentry JD; Neff JR; Nelson M; Daniels W; Perry D; Gatalica Z; Bridge JA
Virchows Arch; 2006 Jun; 448(6):852-6. PubMed ID: 16596382
[TBL] [Abstract][Full Text] [Related]
58. Telomerase reverse transcriptase promotes chemoresistance by suppressing cisplatin-dependent apoptosis in osteosarcoma cells.
Zhang Z; Yu L; Dai G; Xia K; Liu G; Song Q; Tao C; Gao T; Guo W
Sci Rep; 2017 Aug; 7(1):7070. PubMed ID: 28765565
[TBL] [Abstract][Full Text] [Related]
59. Dependence of induction of osteocalcin gene expression on the presence of wild-type p53 in a murine osteosarcoma cell line.
Chandar N; Campbell P; Novak J; Smith M
Mol Carcinog; 1993; 8(4):299-305. PubMed ID: 8280378
[TBL] [Abstract][Full Text] [Related]
60. Expression Analysis for the Identification of Genes Involved in Acquired Resistance to Cisplatin in Osteosarcoma Cells.
Takazawa K; Tsuchiya H; Yoshimichi U; Kanazawa Y; Ii S; Tomita K
Cancer Genomics Proteomics; 2006; 3(6):373-381. PubMed ID: 31394670
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
